Trial Profile
A Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Systemic Sclerosis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Jan 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Diffuse scleroderma
- Focus Therapeutic Use
- 09 Apr 2014 New trial record
- 21 Jul 2011